Skip to content
TrackPodcasts
businessNov 9, 202051:55pending

Vaccine in Sight, What Now for Stocks?

Halftime Report

About this episode

Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks?


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Halftime Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Vaccine in Sight, What Now for Stocks?

Halftime Report

0:00
51:55

More episodes

More from Halftime Report

View all episodes →